TA Ventures
Overview
TA Ventures is a globally-minded and network-driven VC firm investing in early-stage tech startups shaping the industries of tomorrow. They offer speed of execution, proactive support, and access to a broad international network. TA Ventures invests in Pre-Seed, Seed, and occasionally Series A stages with a typical ticket ranging between $100k and $1m and reserve significant capacity for follow-ons. TA Ventures is focused on Software and DeepTech across Health & Bio, Fintech, and complex use cases within the Enterprise stack, with some activity in Consumer, including D2C brands.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| SpeedLabs | Jun 2026 | Seed | Co-investor |
| Blossom Health | Mar 2026 | Series A | Co-investor |
| Blossom Health | Sep 2025 | Series A | Co-investor |
| Liki24 | Jul 2025 | Series A | Co-investor |
| Qanooni | Jun 2025 | Pre Seed | Co-investor |
Key People
Viktoriya Tigipko
Founder And Managing Partner
Colin McSwiggen
Venture Partner And Scientific Advisor
Eveline Buchatskiy
Venture Partner
Igor Buchatskiy
Venture Partner
Maria Ren
Venture Partner SEA
Richard Armstrong
Venture Partner SEA Lead
Igor Semenov
Partner
Oleg Malenkov
Partner
Illia Nadykto
Investor
Hagop K.
Investor Relations
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
